Cargando…
Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma
Uveal melanoma (UM) is the most common primary eye malignancy in adults and up to 50% of patients subsequently develop systemic metastasis. Metastatic uveal melanoma (MUM) is highly resistant to immunotherapy. One of the mechanisms for resistance would be the immune-suppressive tumor microenvironmen...
Autores principales: | Terai, Mizue, Londin, Eric, Rochani, Ankit, Link, Emma, Lam, Bao, Kaushal, Gagan, Bhushan, Alok, Orloff, Marlana, Sato, Takami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072257/ https://www.ncbi.nlm.nih.gov/pubmed/32050636 http://dx.doi.org/10.3390/cancers12020405 |
Ejemplares similares
-
The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
por: Tanaka, Ryota, et al.
Publicado: (2021) -
Genetic Landscape and Emerging Therapies in Uveal Melanoma
por: Seedor, Rino S., et al.
Publicado: (2021) -
Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma
por: Terai, Mizue, et al.
Publicado: (2021) -
Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma
por: Chua, Vivian, et al.
Publicado: (2019) -
Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma
por: Sugase, Takahito, et al.
Publicado: (2020)